Cummings BE, Stucke EM, Coulibaly D, Lawton JG, Sobota RS, Kone AK, Kane B, Guindo B, Tangara B, Sissoko M, Maiga F, Traore K, Diawara A, Traore A, Thera A, Dara A, Niangaly A, Daou M, Diarra I, Tolo Y, Sebastian S, Jain A, Nakajima R, Jasinskas A, Silzel EK, Shrestha B, Ouattara A, Munro JB, Laurens MB, Lyke KE, Tebben K, Bogale H, Plowe CV, Sissoko MS, Kouriba B, Takala-Harrison S, Felgner PL, Silva JC, Doumbo OK, Thera MA, Travassos MA. Plasmodium falciparum gene expression signatures and antibody profiling implicate the fikk, phist, and surf multigene families in severe malaria syndromes. J Infect. 2025 Dec; 91(6):106655.

Dos Santos NSA, de Almeida-J?nior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, Oliveira NFM, Gazzinelli RT, Machado FS, Teixeira SMR. RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. Front Cell Infect Microbiol. 2025; 15:1681807.

G?mez-P?rez GP, Vidal M, Campo JJ, Moncunill G, Jimenez A, V?zquez-Santiago M, Ruiz-Olalla G, Sanz H, Ayestaran A, Angov E, Dutta S, Chitnis C, Chauhan V, James ER, Billingsley PF, Sim BKL, Kremsner PG, Hoffman SL, Lell B, Mordm?ller B, Doba?o C. IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Na?ve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection. Am J Trop Med Hyg. 2025 Dec 03; 113(6):1235-1248.

Forconi CS, Nixon C, Wu HW, Odwar B, Pond-Tor S, Ong'echa JM, Kurtis JD, Moormann AM. T-follicular helper cell profiles differ by malaria antigen and for children compared to adults. Elife. 2025 May 22; 13.

de Oliveira B, Goes WM, Nascimento FC, Carnielli JBT, Ferreira ER, de Carvalho AF, Dos Reis PVM, Pereira M, Ricotta TQN, Dos Santos LM, de Souza RP, Cargnelutti DE, Mottram JC, Teixeira SR, Fernandes AP, Gazzinelli RT. Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine. mSphere. 2025 May 27; 10(5):e0009725.

Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares IS. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol?) as adjuvant. Vaccine. 2024 04 02; 42(9):2394-2406.

Jongo S, Church LWP, Milando F, Qassim M, Schindler T, Rashid M, Tumbo A, Nyaulingo G, Bakari BM, Athuman Mbaga T, Mohamed L, Kassimu K, Simon BS, Mpina M, Zaidi I, Duffy PE, Swanson PA, Seder R, Herman JD, Mendu M, Zur Y, Alter G, Kc N, Riyahi P, Abebe Y, Murshedkar T, James ER, Billingsley PF, Sim BKL, Richie TL, Daubenberger C, Abdulla S, Hoffman SL. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults. J Clin Invest. 2024 Jan 09; 134(6).

Rodrigues da Cunha GM, Azevedo MA, Nogueira DS, Cl?maco MC, Valencia Ayala E, Jimenez Chunga JA, La Valle RJY, da Cunha Galv?o LM, Chiari E, Brito CRN, Soares RP, Nogueira PM, Fujiwara RT, Gazzinelli R, Hincapie R, Chaves CS, Oliveira FMS, Finn MG, Marques AF. a-Gal immunization positively impacts Trypanosoma cruzi colonization of heart tissue in a mouse model. PLoS Negl Trop Dis. 2021 07; 15(7):e0009613.

Figueiredo MM, Dos Santos ARR, Godoi LC, de Castro NS, de Andrade BC, Sergio SAR, Jer?nimo SMB, de Oliveira EJ, Valencia-Portillo RT, Bezerra LM, Goto H, Sanchez MCA, Junqueira C, Teixeira SMR, da Fonseca FG, Gazzinelli RT, Fernandes AP. Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis. J Immunol Res. 2021; 2021:5568077.

Feng G, Wines BD, Kurtovic L, Chan JA, Boeuf P, Mollard V, Cozijnsen A, Drew DR, Center RJ, Marshall DL, Chishimba S, McFadden GI, Dent AE, Chelimo K, Boyle MJ, Kazura JW, Hogarth PM, Beeson JG. Mechanisms and targets of Fc?-receptor mediated immunity to malaria sporozoites. Nat Commun. 2021 03 19; 12(1):1742.